Osiris Therapeutics, Inc researches, develops, manufactures, markets, and distributes regenerative medicine products in the United States. Its products include Grafix and Stravix for treating chronic wounds of diabetic foot ulcers, venous leg ulcers, pressure ulcers, arterial ulcers, and severe burns, as well as surgical and trauma wounds; BIO4 for bone repair and regeneration in spine, trauma, extremity, cranial, and foot and ankle surgeries; and Cartiform for treating articular cartilage lesions in the knee and other joints.
Read More…
Industry, Sector and Symbol
Industry Biological products, except diagnostic
Sub-IndustryBiotechnology
SectorMedical
Phone443-545-1800
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableOptionable
Osiris Therapeutics (OTCMKTS:OSIR) Frequently Asked Questions
What is Osiris Therapeutics' stock symbol?
Osiris Therapeutics trades on the OTCMKTS under the ticker symbol "OSIR."
Has Osiris Therapeutics been receiving favorable news coverage?
Media stories about OSIR stock have trended very negative this week, InfoTrie Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Osiris Therapeutics earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned media stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Osiris Therapeutics.
Who are some of Osiris Therapeutics' key competitors?
Some companies that are related to Osiris Therapeutics include Halozyme Therapeutics (HALO), Iovance Biotherapeutics (IOVA), Acceleron Pharma (XLRN), Crispr Therapeutics (CRSP), Regenxbio (RGNX), Denali Therapeutics (DNLI), Momenta Pharmaceuticals (MNTA), Coherus Biosciences (CHRS), Audentes Therapeutics (BOLD), Orchard Therapeutics (ORTX), Editas Medicine (EDIT), Alector (ALEC), Sangamo Therapeutics (SGMO), Aerie Pharmaceuticals (AERI) and Fate Therapeutics (FATE).
What other stocks do shareholders of Osiris Therapeutics own?
Who are Osiris Therapeutics' key executives?
Osiris Therapeutics' management team includes the folowing people:
- Mr. Jason Keefer, Interim Pres & CEO (Age 46)
- Dr. Alla N. Danilkovitch, Chief Scientific Officer (Age 54)
- Mr. Joel David Rogers, Interim Chief Financial Officer (Age 56)
- Mr. Edward Yip, Chief Legal Officer & Corp. Sec.
- Mr. Laine Dyess, VP of Sales
How do I buy shares of Osiris Therapeutics?
Shares of OSIR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
How big of a company is Osiris Therapeutics?
What is Osiris Therapeutics' official website?
How can I contact Osiris Therapeutics?
Osiris Therapeutics' mailing address is 7015 ALBERT EINSTEIN DRIVE, COLUMBIA MD, 21046. The biotechnology company can be reached via phone at 443-545-1800 or via email at [email protected]
MarketBeat Community Rating for Osiris Therapeutics (OTCMKTS OSIR)
MarketBeat's community ratings are surveys of what our community members think about Osiris Therapeutics and other stocks. Vote "Outperform" if you believe OSIR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OSIR will underperform the S&P 500 over the long term. You may vote once every thirty days.
